Samsung Medical Center Begins Development of 'On-Device Real-Time Ultrasound AI' for Emergency and Critical Care
Selected for Pan-Ministerial Advanced Medical Device R&D Program
Five-Year, 5 Billion Won Research Project with Samsung Medison, Sungkyunkwan University, and Ewha Womans University
Samsung Medical Center is embarking on the development of an 'on-device real-time ultrasound AI' technology that can be utilized in emergency and critical care settings.
Researchers undertaking the development of 'On-Device Real-Time Ultrasound AI' for emergency and critical care patients. Samsung Medical Center
View original imageOn June 16, Samsung Medical Center announced that it has been selected for the 'Core Medical Device Technology and Product Development' category as part of the first phase of the 2026 Pan-Ministerial Advanced Medical Device R&D Program.
This project will be led by Samsung Medison, with Samsung Medical Center, Sungkyunkwan University, and Ewha Womans University participating as joint research institutions. The total research funding amounts to 5 billion won over five years. The principal investigator at Samsung Medical Center is Professor Park Sungji of the Department of Cardiology, and the principal investigator at Sungkyunkwan University School of Medicine is Professor Jung Myungjin (Director of the Data Science Research Institute and Department of Radiology at Samsung Medical Center).
The research team aims to develop an AI-based diagnostic system that addresses the limitations of Point of Care Ultrasound (POCUS), which is used in environments such as emergency rooms (ER), intensive care units (ICU), and patient transport settings.
POCUS can be performed rapidly at the patient's bedside and is highly useful in emergency and critical care. However, it has the limitation of being heavily dependent on the operator's skill for acquiring appropriate images and interpreting them.
The goal of this research is to implement an integrated diagnostic system that supports the entire process from image acquisition to assessment and analysis, applying on-device AI technology that operates directly on the ultrasound equipment without network connectivity.
The developed technology will integrate a scan guide to help secure standard views, an image quality assessment (QA) feature that automatically filters out images unsuitable for diagnosis, and quantitative analysis and abnormality detection functions essential for emergency decision-making.
In particular, for cardiac POCUS, the team plans to clinically validate and bring to product level functions needed in emergencies, such as automatic evaluation of left ventricular ejection fraction (LVEF), detection of regional wall motion abnormality (RWMA), and identification of findings suggestive of pericardial effusion and cardiac tamponade.
Professor Park Sungji stated, "POCUS plays a critical role in emergency settings, but securing standard images and achieving diagnostic accuracy remain barriers to broader adoption. We aim to enhance field usability by implementing an AI-based integrated diagnostic system that supports the entire process from ultrasound imaging to assessment and analysis."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Previously, Samsung Medical Center participated as a joint research institution in the pan-ministerial full-cycle medical device R&D project led by Insung Medical, successfully localizing cardiopulmonary oxygenator equipment that was previously 100% dependent on imports, and obtained the first domestic approval from the Ministry of Food and Drug Safety.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.